Evidence map›Paper›PMID 16282349›Full record

ArticleBlood2006

G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth.

Quan-Sheng Zhu, Ling Xia, Gordon B Mills, Clifford A Lowell, Ivo P Touw, Seth J Corey

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 146 citations in OpenAlex.

  1. CAR-T cell immunotherapy in rhabdomyosarcoma.Journal of translational medicine · 2026
    Review
  2. Review
  3. Expanding the Spectrum ofJournal of clinical medicine · 2025
    Article
  4. Oxidant/Antioxidant Status in Patients withIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025
    Article
  5. Article
  6. Neutrophil diversity and function in health and disease.Signal transduction and targeted therapy · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Molecules and cells · 2020
    Review
  18. Article
  19. Review
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Quan-Sheng ZhuDivision of Pediatrics, University of Texas--M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Ling Xia
Gordon B Mills
Clifford A Lowell
Ivo P Touw
Seth J Corey
University of California, San Francisco · US

Funding

LYN AND JAK2 IN GCSF PROLIFERATIVE SIGNALINGR29CA074422 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI COREY, SETH JOEL · 1997 to 2001
$198k
NCI NIH HHS R29CA74422
6 · The paper itself

Abstract

Granulocyte colony-stimulating factor (G-CSF) drives the production, survival, differentiation, and inflammatory functions of granulocytes. Reactive oxygen species (ROSs) provide a major thrust of the inflammatory response, though excessive ROSs may be deleterious. G-CSF stimulation showed a time- and dose-dependent increase in ROS production, correlating with activation of Lyn and Akt. Inhibition of Lyn, PI3-kinase, and Akt abrogated G-CSF-induced ROS production. This was also blocked by DPI, a specific inhibitor of NADPH oxidase. Following G-CSF stimulation, neutrophils from Lyn-/- mice produced less ROSs than wild-type littermates. G-CSF induced both serine phosphorylation and membrane translocation of p47phox, a subunit of NADPH oxidase. Because patients with a truncated G-CSF receptor have a high risk of developing acute myeloid leukemia (AML), we hypothesized that dysregulation of ROSs contributes to leukemogenesis. Cells expressing the truncated G-CSF receptor produced more ROSs than those with the full-length receptor. G-CSF-induced ROS production was enhanced in bone marrow-derived neutrophils expressing G-CSFRdelta715, a truncated receptor. The antioxidant N-acetyl-L-cysteine diminished G-CSF-induced ROS production and cell proliferation by inhibiting Akt activation. These data suggest that the G-CSF-induced Lyn-PI3K-Akt pathway drives ROS production. One beneficial effect of therapeutic targeting of Lyn-PI3K-kinase-Akt cascade is abrogating ROS production.

Indexed as

AcetylcysteineAnimalsBone Marrow CellsCell LineCell ProliferationDose-Response Relationship, DrugDrug DesignEnzyme InhibitorsGranulocyte Colony-Stimulating FactorHumansLeukemia, Myeloid, AcuteMiceMice, KnockoutNADPH OxidasesNeutrophilsPhosphatidylinositol 3-KinasesAcetylcysteineEnzyme InhibitorsGranulocyte Colony-Stimulating Factorlyn protein-tyrosine kinaseNADPH Oxidasesneutrophil cytosolic factor 1Phosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPhosphoproteinsProto-Oncogene Proteins c-aktReactive Oxygen SpeciesReceptors, Granulocyte Colony-Stimulating Factorsrc-Family Kinases

Identifiers

PMID16282349
PMCPMC1895701
OpenAlexW2053650018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.